Multidimensional barriers and facilitators to early phase clinical trial (EPCT) participation among diverse patients with advanced solid tumors.
117 Background: Early phase clinical trials (EPCTs) are critical for oncology innovation and access to novel therapies, yet members of minoritized communities remain underrepresented as a result of complex psychosocial, structural, and systemic barriers. Understanding the varying perspectives of patients, careg...